Neurocrine Biosciences total non-operating income/expense for the twelve months ending December 31, 2024 was $-0.085B, a 204.06% decline year-over-year.
Neurocrine Biosciences annual total non-operating income/expense for 2024 was $-0.085B, a 204.06% decline from 2023.
Neurocrine Biosciences annual total non-operating income/expense for 2023 was $0.081B, a 331.34% decline from 2022.
Neurocrine Biosciences annual total non-operating income/expense for 2022 was $-0.035B, a 3090.91% increase from 2021.
Neurocrine Biosciences Total Non-Operating Income/Expense 2010-2024 | NBIX